IGF2BP3 and melanoma: Meanwhile, we explored the obtainable effects of anti-tumor drugs for melanoma patients with IGF2BP3 mutations, revealing significantly epigenetic regulators of melanoma and novel approaches in precise and personalized medicine therapy.